Reduced MBF Regimen for Patients >=55 Years With Myeloid Malignancies

Clinical trial NCT05436561 · RECRUITING

Trial details

NCT number: NCT05436561
Sponsor: Shanghai Jiao Tong University School of Medicine
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Disease-free Survival

Start date: 2022-06-01
Primary completion: 2026-12-01
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.